Searchable abstracts of presentations at key conferences in endocrinology

ea0050p361 | Reproduction | SFEBES2017

Non-cardiac maternal and fetal outcomes in Turner Syndrome pregnancies.

Spain Geraldine , MacKillop Lucy , Turner Helen

Background: Despite new, albeit draft, international guidelines there remains limited data and guidance on the non-cardiac obstetric management and outcomes in women with Turner Syndrome (TS).AIMS: This retrospective single centre audit aimed to assess the maternal and fetal outcomes in a large single centre cohort.METHODS: We identified 110 women under our care with TS. Of these, 28 women had attempted to achiev...

ea0050p361 | Reproduction | SFEBES2017

Non-cardiac maternal and fetal outcomes in Turner Syndrome pregnancies.

Spain Geraldine , MacKillop Lucy , Turner Helen

Background: Despite new, albeit draft, international guidelines there remains limited data and guidance on the non-cardiac obstetric management and outcomes in women with Turner Syndrome (TS).AIMS: This retrospective single centre audit aimed to assess the maternal and fetal outcomes in a large single centre cohort.METHODS: We identified 110 women under our care with TS. Of these, 28 women had attempted to achiev...

ea0044oc2.5 | Neuroendocrinology and Reproduction | SFEBES2016

Ipilimumab Hypophysitis – single centre experience of an emerging endocrine diagnosis

Marc Lai Zhuangming , Spain Lavinia , Gore Martin , Larkin James , Morganstein Daniel

Background: Ipilimumab is a cytotoxic T-lymphocyte antigen-4 (CTLA-4) inhibitor that improves survival in advanced melanoma. However, ipilimumab induces immune-related adverse events including hypophysitis and hypopituitarism. We describe one of the largest single centre series of ipilimumab induced hypophysitis.Methods: We retrospectively analysed all patients (n=301) treated with ipilimumab either as a monotherapy or in combination with nivolu...